The Douglas-born director talks about his formative years in Cork and the pressure for success with We Live In Time following the flop of his previous film John Crowley at the Irish premiere of ...

In the trailer, a pivotal scene shows Florence Pugh's character, Almut, going into labour, leading director John Crowley to offer insights into the filming process of this intense moment to BFI.

Financial giants have made a conspicuous bearish move on Regeneron Pharmaceuticals. Our analysis of options history for Regeneron Pharmaceuticals REGN revealed 10 unusual trades. Delving into the ...

English was named All-Star left corner-back in 2018 — Limerick’s breakthrough year. The 30-year-old won six Munster SHC medals and three NHL titles. English said: “It is not easy to step ...

Pat Crowley, a former award-winning reporter at the Cincinnati Enquirer, is being remembered after he died last weekend at 63.Crowley died unexpectedly at his home in Fort Thomas on Dec. 28.

More info The new directly-elected mayor of Limerick asked Simon Harris that €2 billion of the Apple tax fund be given directly to the city and county. In a personal plea to Mr Harris ...

It’s free, but you have to watch the occasional block of ads. It’s worth it, though, for these John Wick movies, which are some of the best action movies ever made. Any action movie fan will ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Regeneron has signed a collaboration deal potentially worth $1 billion with RNAi experts Alnylam Pharmaceuticals, to develop and commercialise drugs targeting eye, central nervous system (CNS ...

John Travolta, just like Olivia Newton-John, skyrocketed to fame following the release of the film musical Grease in 1978, the year after he danced his way across the big screen in Saturday Night ...

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...